Total Payments
$854.41
2023 Payments
$98.67
Companies
11
Transactions
53
Medicare Patients
1,397
Medicare Billing
$160,463
Payment Breakdown by Category
Food & Beverage$854.41 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $854.41 | 53 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $383.87 | 22 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $109.74 | 8 | $0 (2022) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $79.04 | 5 | $0 (2021) |
| E.R. Squibb & Sons, L.L.C. | $77.55 | 5 | $0 (2023) |
| Merck Sharp & Dohme LLC | $54.22 | 4 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $40.93 | 3 | $0 (2021) |
| AbbVie Inc. | $39.00 | 2 | $0 (2021) |
| Alexion Pharmaceuticals, Inc. | $21.27 | 1 | $0 (2022) |
| Medtronic, Inc. | $18.95 | 1 | $0 (2022) |
| Allergan, Inc. | $16.71 | 1 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $98.67 | 4 | Novartis Pharmaceuticals Corporation ($76.47) |
| 2022 | $169.62 | 10 | Novartis Pharmaceuticals Corporation ($59.60) |
| 2021 | $189.27 | 11 | Novartis Pharmaceuticals Corporation ($60.70) |
| 2020 | $117.76 | 7 | Novartis Pharmaceuticals Corporation ($59.68) |
| 2019 | $195.56 | 15 | Novartis Pharmaceuticals Corporation ($127.42) |
| 2018 | $83.53 | 6 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) ($57.97) |
All Payment Transactions
53 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/16/2023 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $24.98 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 03/09/2023 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $23.57 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 01/19/2023 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $27.92 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 01/18/2023 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $22.20 | General |
| Category: Cardiovascular | ||||||
| 12/06/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $12.80 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 11/16/2022 | Merck Sharp & Dohme LLC | DIFICID (Drug) | Food and Beverage | In-kind items and services | $15.84 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 11/16/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $14.02 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 11/03/2022 | Alexion Pharmaceuticals, Inc. | SOLIRIS (Biological) | Food and Beverage | In-kind items and services | $21.27 | General |
| Category: Rare Disease | ||||||
| 09/22/2022 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $21.33 | General |
| Category: CARDIOVASCULAR | ||||||
| 07/28/2022 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $17.23 | General |
| Category: CARDIOVASCULAR | ||||||
| 04/18/2022 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $21.04 | General |
| Category: CARDIOVASCULAR | ||||||
| 03/28/2022 | Medtronic, Inc. | LINQ II (Device) | Food and Beverage | In-kind items and services | $18.95 | General |
| Category: Cardiac Diagnostics and Monitoring | ||||||
| 03/16/2022 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $14.49 | General |
| Category: Cardiovascular | ||||||
| 02/04/2022 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $12.65 | General |
| Category: Cardiovascular | ||||||
| 12/08/2021 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $20.31 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/08/2021 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $20.31 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/23/2021 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $13.22 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/14/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $13.09 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/09/2021 | Merck Sharp & Dohme Corporation | DIFICID (Drug), ZINPLAVA | Food and Beverage | In-kind items and services | $13.98 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 09/08/2021 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $20.08 | General |
| Category: CARDIOVASCULAR | ||||||
| 06/11/2021 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $21.07 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 05/18/2021 | AbbVie Inc. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $19.39 | General |
| Category: ANTI-INFECTIVE | ||||||
| 04/01/2021 | AbbVie Inc. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $19.61 | General |
| Category: ANTI-INFECTIVE | ||||||
| 03/19/2021 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $14.36 | General |
| Category: Cardiovascular | ||||||
| 02/05/2021 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $13.85 | General |
| Category: Cardiovascular | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 319 | 504 | $194,523 | $39,959 |
| 2022 | 5 | 364 | 593 | $418,408 | $44,583 |
| 2021 | 5 | 340 | 489 | $342,408 | $36,441 |
| 2020 | 6 | 374 | 486 | $358,341 | $39,480 |
Total Patients
1,397
Total Services
2,072
Medicare Billing
$160,463
Procedure Codes
20
All Medicare Procedures & Services
20 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 108 | 220 | $97,268 | $19,595 | 20.1% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 91 | 164 | $42,644 | $9,864 | 23.1% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 107 | 107 | $46,499 | $8,921 | 19.2% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 13 | 13 | $8,112 | $1,578 | 19.5% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 181 | 381 | $273,997 | $29,336 | 10.7% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 101 | 102 | $75,281 | $7,914 | 10.5% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 46 | 71 | $35,612 | $3,711 | 10.4% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 11 | 12 | $18,677 | $2,022 | 10.8% |
| 99497 | Advance care planning, first 30 minutes | Facility | 2022 | 25 | 27 | $14,842 | $1,600 | 10.8% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 145 | 276 | $204,544 | $21,705 | 10.6% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 106 | 106 | $80,953 | $8,620 | 10.6% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 39 | 53 | $27,162 | $2,931 | 10.8% |
| 99497 | Advance care planning by the physician or other qualified health care professional, first 30 minutes | Facility | 2021 | 36 | 40 | $22,504 | $2,413 | 10.7% |
| 99217 | Hospital observation care on day of discharge | Facility | 2021 | 14 | 14 | $7,245 | $772.24 | 10.7% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 133 | 221 | $163,783 | $18,176 | 11.1% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2020 | 97 | 97 | $74,080 | $8,086 | 10.9% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 34 | 34 | $48,943 | $5,257 | 10.7% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 46 | 67 | $34,337 | $3,857 | 11.2% |
| 99497 | Advance care planning by the physician or other qualified health care professional | Facility | 2020 | 53 | 56 | $31,505 | $3,525 | 11.2% |
| 99217 | Hospital observation care on day of discharge | Facility | 2020 | 11 | 11 | $5,693 | $578.04 | 10.2% |
About Dr. Bonnie Patrick, MD
Dr. Bonnie Patrick, MD is a Internal Medicine healthcare provider based in Biddeford, Maine. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/15/2007. The National Provider Identifier (NPI) number assigned to this provider is 1992856249.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Bonnie Patrick, MD has received a total of $854.41 in payments from pharmaceutical and medical device companies, with $98.67 received in 2023. These payments were reported across 53 transactions from 11 companies. The most common payment nature is "Food and Beverage" ($854.41).
As a Medicare-enrolled provider, Patrick has provided services to 1,397 Medicare beneficiaries, totaling 2,072 services with total Medicare billing of $160,463. Data is available for 4 years (2020–2023), covering 20 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Internal Medicine, Internal Medicine
- Location Biddeford, ME
- Active Since 01/15/2007
- Last Updated 08/18/2025
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1992856249
Products in Payments
- ENTRESTO (Drug) $383.87
- XARELTO (Drug) $109.74
- LifeVest (Device) $79.04
- ELIQUIS (Drug) $77.55
- DIFICID (Drug) $54.22
- DALVANCE (Drug) $39.00
- BRILINTA (Drug) $27.71
- SOLIRIS (Biological) $21.27
- LINQ II (Device) $18.95
- AVYCAZ (Drug) $16.71
- LOKELMA (Drug) $13.22
- KYPHON Balloon Kyphoplasty (Device) $13.13
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Biddeford
Dr. Peter Rubin, M.d, M.D
Internal Medicine — Payments: $31,481
Internal Medicine $31,481
Yasmin Mahal, Do, DO
Internal Medicine — Payments: $2,642
Internal Medicine $2,642
Steven Cutone, D.o, D.O
Internal Medicine — Payments: $2,606
Internal Medicine $2,606
Jennifer Cutone, M.d, M.D
Internal Medicine — Payments: $2,262
Internal Medicine $2,262
Dr. Mahesh Bandara, M.d, M.D
Internal Medicine — Payments: $1,733
Internal Medicine $1,733
Dr. Woodrow Lee, Do, DO
Internal Medicine — Payments: $1,712
Internal Medicine $1,712